Radiology Doctors in Sylvania, OH Accepting Medicare

5 Radiology doctors found. Showing 1 - 5

Dr. Jeffrey Alan Forquer, M.D. Radiology - Radiation Oncology Medicare: Accepting Medicare Assignments Practice Location: 5300 Harroun Rd Ste 10, Sylvania, OH 43560 Phone: 419-824-1952    Fax: 419-824-0344

Jalal Hyder, DO Radiology - Radiation Oncology Medicare: Accepting Medicare Assignments Practice Location: 5300 Harroun Rd Ste 10, Sylvania, OH 43560 Phone: 419-824-1952    Fax: 419-824-0344

Dr. Eric Paul Kielhorn, M.D. Radiology - Radiation Oncology Medicare: Accepting Medicare Assignments Practice Location: 5300 Harroun Rd Ste 10, Sylvania, OH 43560 Phone: 419-824-1952    Fax: 419-824-0344

Dr. Dean Michael Hountras, M.D. Radiology - Diagnostic Radiology Medicare: Accepting Medicare Assignments Practice Location: 4629 Cinnamon Lane, Sylvania, OH 43560 Phone: 419-471-0048    Fax: 419-471-1307

Steven Rubin, MD Radiology - Radiation Oncology Medicare: Accepting Medicare Assignments Practice Location: 5300 Harroun Rd Ste 10, Sylvania, OH 43560 Phone: 419-824-1952    Fax: 419-824-0344

News Archive

Brain's learning capacity recharges during light, dreamless slumber

Scientists have long puzzled over the many hours we spend in light, dreamless slumber. But a new study from the University of California, Berkeley, suggests we're busy recharging our brain's learning capacity during this traditionally undervalued phase of sleep, which can take up half the night.

Many men with androgen deficiency do not receive treatment

The majority of men with androgen deficiency may not be receiving treatment despite having sufficient access to care, according to a report in the May 26 issue of Archives of Internal Medicine.

Gay and bisexual men may be at far higher risk for eating disorders

In the first population-based study of its kind, the researchers found that gay and bisexual men have higher rates of eating disorders. The findings are reported in the April 2007 issue of International Journal of Eating Disorders.

Anacor initiates dosing in AN2728 Phase 2b trial for psoriasis

Anacor Pharmaceuticals announced today that the first patient has been dosed in a Phase 2b trial of AN2728, a topical anti-inflammatory product candidate for the treatment of psoriasis. Psoriasis is a chronic inflammatory skin disease that affects approximately 7.5 million people in the United States and over 100 million people worldwide.

Read more Medical News

› Verified 5 days ago